208 related articles for article (PubMed ID: 25803132)
1. Characteristics and viral propagation properties of a new human diploid cell line, Walvax-2, and its suitability as a candidate cell substrate for vaccine production.
Ma B; He LF; Zhang YL; Chen M; Wang LL; Yang HW; Yan T; Sun MX; Zheng CY
Hum Vaccin Immunother; 2015; 11(4):998-1009. PubMed ID: 25803132
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal characterization of MRC-5 cell banks utilizing G-banding technique.
Rosolowsky M; McKee R; Nichols W; Garfinkle B
Dev Biol Stand; 1998; 93():109-17. PubMed ID: 9737385
[TBL] [Abstract][Full Text] [Related]
3. The hUC-MSCs cell line CCRC-1 represents a novel, safe and high-yielding HDCs for the production of human viral vaccines.
Chen P; Zhang KH; Na T; Wang L; Yin WD; Yuan BZ; Wang JZ
Sci Rep; 2017 Oct; 7(1):12484. PubMed ID: 28970485
[TBL] [Abstract][Full Text] [Related]
4. Possibilities of vaccine manufacture in human diploid cell strains with a serum replacement factor.
Candal FJ; George VG; Ades EW
Biologicals; 1991 Jul; 19(3):213-8. PubMed ID: 1659430
[TBL] [Abstract][Full Text] [Related]
5. Interferon Inhibition Enhances the Pilot-Scale Production of Rabies Virus in Human Diploid MRC-5 Cells.
Yang X; Wan M; Cai L; Hou A; Sun B; Zhou Y; Gao F; Su W; Jiang C
Viruses; 2021 Dec; 14(1):. PubMed ID: 35062253
[TBL] [Abstract][Full Text] [Related]
6. Human Embryonic Stem Cell-Derived Neurons Are Highly Permissive for Varicella-Zoster Virus Lytic Infection.
Sadaoka T; Schwartz CL; Rajbhandari L; Venkatesan A; Cohen JI
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046461
[TBL] [Abstract][Full Text] [Related]
7. [M-29 human diploid cells line--a substrate for the production of antiviral vaccines].
Borisova TK; Zverev VV; Mironova LL; Koniushko OI; Zabiiaka IuI; Shukhmina NR; Vashchenko VI
Zh Mikrobiol Epidemiol Immunobiol; 2011; (3):43-8. PubMed ID: 21809644
[TBL] [Abstract][Full Text] [Related]
8. Use of human diploid cell MRC-5, for production of measles and rubella virus vaccines.
Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P
Dev Biol Stand; 1976 Dec 13-15; 37():297-300. PubMed ID: 1031692
[TBL] [Abstract][Full Text] [Related]
9. Human diploid cell strains (HDCS) viral vaccines.
Fletcher MA; Hessel L; Plotkin SA
Dev Biol Stand; 1998; 93():97-107. PubMed ID: 9737384
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.
Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH
Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718
[TBL] [Abstract][Full Text] [Related]
11. Evolution of Diploid Progenitor Lung Cell Applications: From Optimized Biotechnological Substrates to Potential Active Pharmaceutical Ingredients in Respiratory Tract Regenerative Medicine.
Laurent A; Abdel-Sayed P; Hirt-Burri N; Scaletta C; Michetti M; de Buys Roessingh A; Raffoul W; Applegate LA
Cells; 2021 Sep; 10(10):. PubMed ID: 34685505
[TBL] [Abstract][Full Text] [Related]
12. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
[TBL] [Abstract][Full Text] [Related]
13. The present status of rabies vaccine development and clinical experience with rabies vaccine.
Roumiantzeff M
Southeast Asian J Trop Med Public Health; 1988 Dec; 19(4):549-61. PubMed ID: 3070767
[TBL] [Abstract][Full Text] [Related]
14. Human diploid MRC-5 cells exhibit several critical properties of human umbilical cord-derived mesenchymal stem cells.
Zhang K; Na T; Wang L; Gao Q; Yin W; Wang J; Yuan BZ
Vaccine; 2014 Nov; 32(50):6820-7. PubMed ID: 25086263
[TBL] [Abstract][Full Text] [Related]
15. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
[TBL] [Abstract][Full Text] [Related]
16. Nonhuman primate diploid cells for vaccine production.
Petricciani JC
Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399
[TBL] [Abstract][Full Text] [Related]
17. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
Rourou S; Ben Zakkour M; Kallel H
Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054
[TBL] [Abstract][Full Text] [Related]
18. Suitability of NIID-MDCK cells as a substrate for cell-based influenza vaccine development from the perspective of adventitious virus susceptibility.
Hamamoto I; Takahashi H; Shimasaki N; Nakamura K; Mizuta K; Sato K; Nishimura H; Yamamoto N; Hasegawa H; Odagiri T; Tashiro M; Nobusawa E
Microbiol Immunol; 2022 Jul; 66(7):361-370. PubMed ID: 35545856
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
20. Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
Gränicher G; Coronel J; Pralow A; Marichal-Gallardo P; Wolff M; Rapp E; Karlas A; Sandig V; Genzel Y; Reichl U
Vaccine; 2019 Nov; 37(47):7019-7028. PubMed ID: 31005427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
